• 1
    Port F.K., Wolfe R.A., Mauger E.A., Berling D.P., Jiang K. (1993) Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 270: 133943.
  • 2
    Humar A., Gillingham K.J., Payne W.D., Dunn D.L., Sutherland D.E., Matas A.J. (1999) Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation 68: 187983.
  • 3
    Helantera I., Loginov R., Koskinen P., Tornroth T., Gronhagen-Riska C., Lautenschlager I. (2005) Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts. Nephrol Dial Transplant 20: 7906.
  • 4
    Helantera I., Egli A., Koskinen P., Lautenschlager I., Hirsch H.H. (2010) Viral impact on long-term kidney graft function. Infect Dis Clin North Am 24: 33971.
  • 5
    Kotton C.N., Kumar D., Caliendo A.M., Asberg A., Chou S., Danziger-Isakov L., Humar A. (2013) Updated International Consensus Guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 96(4): 33360.
  • 6
    Nett P.C., Heisey D.M., Fernandez L.A., Sollinger H.W., Pirsch J.D. (2004) Association of cytomegalovirus disease and acute rejection with graft loss in kidney transplantation. Transplantation 78: 103641.
  • 7
    Meier-Kriesche H.U., Schold J.D., Srinivas T.R., Kaplan B. (2004) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 37883.
  • 8
    Watkins R.R., Lemonovich T.L., Razonable R.R. (2012) Immune response to CMV in solid organ transplant recipients: current concepts and future directions. Expert Rev Clin Immunol 8: 38393.
  • 9
    Britt W.J., Mach M. (1996) Human cytomegalovirus glycoproteins. Intervirology 39: 40112.
  • 10
    Gyulai Z., Endresz V., Burian K., Pincus S., Toldy J., Cox W.I., Meric C., Plotkin S., Gonczol E., Berencsi K. (2000) Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs. J Infect Dis 181: 153746.
  • 11
    Meyer H., Sundqvist V.A., Pereira L., Mach M. (1992) Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. J Gen Virol 73 (Pt 9): 237583.
  • 12
    Pignatelli S., Dal Monte P., Rossini G., Landini M.P. (2004) Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 14: 383410.
  • 13
    Elkington R., Shoukry N.H., Walker S., Crough T., Fazou C., Kaur A., Walker C.M., Khanna R. (2004) Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. Eur J Immunol 34: 321626.
  • 14
    Boppana S.B., Rivera L.B., Fowler K.B., Mach M., Britt W.J. (2001) Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344: 136671.
  • 15
    Ishibashi K., Tokumoto T., Tanabe K., Shirakawa H., Hashimoto K., Kushida N., Yanagida T., Inoue N., Yamaguchi O., Toma H., Suzutani T. (2007) Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes. Clin Infect Dis 45: 607.
  • 16
    Ishibashi K., Tokumoto T., Shirakawa H., Hashimoto K., Ikuta K., Kushida N., Yanagida T., Shishido K., Aikawa K., Toma H., Inoue N., Yamaguchi O., Tanabe K., Suzutani T. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors. Transpl Infect Dis 13: 31823.
  • 17
    Ishibashi K., Tokumoto T., Shirakawa H., Hashimoto K., Kushida N., Yanagida T., Shishido K., Aikawa K., Yamaguchi O., Toma H., Tanabe K., Suzutani T. (2008) Strain-specific seroepidemiology and reinfection of cytomegalovirus. Microbes Infect 10: 13639.
  • 18
    Elkington R., Walker S., Crough T., Menzies M., Tellam J., Bharadwaj M., Khanna R. (2003) Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 77: 522640.
  • 19
    Hegde N.R., Dunn C., Lewinsohn D.M., Jarvis M.A., Nelson J.A., Johnson D.C. (2005) Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J Exp Med 202: 110919.